Biocept Inc (OTCPK:BIOCQ)
$ 0.0002 0 (0%) Market Cap: 1,000.00 Enterprise Value: 4.96 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Q1 2022 Biocept Inc Earnings Call Transcript

Jun 07, 2022 / 08:00PM GMT
Release Date Price: $47.1 (+9.03%)
Operator

Welcome to the Biocept business update conference call. (Operator Instructions) Please note this event is being recorded. I would now like to turn the conference call over to Jody Cain. Please go ahead.

Jody Cain
LHA Investor Relations - IR

This is Jody Cain with LHA. Thank you all for participating in today's call. Joining me from Biocept are Sam Riccitelli, Chairman and Interim President and Chief Executive Officer; and Antonino Morales, Interim Chief Financial Officer, who will be available for the Q&A session.

During this call, management will be making a number of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical facts and, generally, can be identified by terms such as anticipates, estimates, believes, could, expect, intends, may, plan, potential, predict, projects, should, will, would, or the negative of those terms.

Forward-looking statements involve known and unknown risks, uncertainties, and other

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot